A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.66 by $0.04. Bessemer Group Inc. now owns 1,903,596 shares of the medical instruments supplier's stock valued at $113,855,000 after buying an additional 1,863,424 shares during the period. Caisse DE Depot ET Placement DU Quebec lifted its stake in DENTSPLY SIRONA by 4.4% in the 3rd quarter.
The stock decreased 3.31% or $2.26 during the last trading session, reaching $66.04. Bessemer Group Inc. grew its holdings in shares of DENTSPLY SIRONA by 4,638.6% in the 3rd quarter. A total of 2,678,452 shares exchanged hands during the intra-day trade contrast with its average trading volume of 1.68M shares, while its relative volume stands at 1.59. Thompson Siegel & Walmsley LLC boosted its stake in shares of DENTSPLY SIRONA by 41.4% during the 3rd quarter. Acrospire Investment Management LLC purchased a new position in DENTSPLY SIRONA in the second quarter worth $113,000. According to their observations and findings, the stock could provide a high EPS of $0.83/share and a low EPS of $0.8/share. Briefly looking at some recent volatility numbers, we can see that shares have been noted at 1.25% for the week, and 1.40% for the past month. Finally, Jefferies Group LLC lowered their target price on DENTSPLY SIRONA from $70.00 to $68.00 and set a "buy" rating for the company in a research note on Monday.
According to Zacks Investment Research, DENTSPLY International Inc. has a Consensus Recommendation of 1.46. They issued an "overweight" rating and a $75.00 price target on the stock. Robert W. Baird reissued an "outperform" rating and set a $67.00 target price (down previously from $69.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, October 4th. Finally, BidaskClub cut shares of DENTSPLY SIRONA from a "strong-buy" rating to a "buy" rating in a report on Saturday, December 2nd. The company presently has an average rating of "Hold" and an average target price of $69.15. At the time of writing, the consensus target price for the company is $72.08.
Top Pick for Wednesday: DENTSPLY SIRONA Inc.
BNDES confirma devolução de R$ 130 bi ao Tesouro neste ano
Trata-se do menor valor nominal de desembolsos desde 2007, quando foram concedidos R $ 64,89 bilhões em empréstimos. Segundo a Folha, o FAT pede que sejam devolvidos R $ 20 bilhões para gastos com seguro-desemprego e abono salarial.
The Dow Jones Industrial Average (DJI - 25,385.80) picked up 102.8 points, or 0.4%, after peaking at 25,439.78 in intraday trading.
Among 19 analysts covering Dentsply International (NASDAQ:XRAY), 13 have Buy rating, 1 Sell and 5 Hold. The firm has a market cap of $14,410.00, a PE ratio of -18.03, a price-to-earnings-growth ratio of 2.49 and a beta of 1.31. It's now trading about -5.12% below its 52-week high. Eqis Capital Management has 0.02% invested in DENTSPLY SIRONA Inc. The Return on Equity (ROE) value stands at -10.2%.
Analysts believe that the company has the potential to earn average revenue of $1.06 Billion for the current quarter.
The Stock now has Analyst' mean Recommendation of 2.3 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
Wild rallies past Blackhawks after 'embarrassing' start
For the Wild to be down just one goal after one period to the Blackhawks was a surprise - or as Boudreau put it, "amazing". Kane has been named to the All-Star team every season in which a game was played since his sophomore season of 2008-09.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 12th. Shareholders of record on Friday, December 29th will be issued a dividend of $0.0875 per share. The ex-dividend date is Thursday, December 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.56%. Barrington Research upgraded DENTSPLY SIRONA Inc.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,409 shares of the firm's stock in a transaction on Monday, January 8th. Checking in on current price action, company shares had recently touched 62.47. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. A beta below 1 might indicate that the stock is less volatile than the market.
TRADEMARK VIOLATION NOTICE: This piece was originally reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this piece on another website, it was copied illegally and reposted in violation of USA and worldwide copyright and trademark legislation.
Now focusing our attention on earnings data, we were able to identify that EPS consensus estimate for DENTSPLY SIRONA Inc. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two divisions, Dental and Healthcare Consumables; and Technologies.
A 'Scandal' And 'How To Get Away With Murder' Crossover Is Happening
Though an official airdate has not yet been released, according to reports , the crossover event will air sometime in the spring. The Scandal edition was directed by actor Tony Goldwyn , who portrays Pope's on and off again lover, Fitzgerald Grant III.